Lancashire Teaching Hospitals NHS Foundation Trust Royal Preston Hospital

Preston PR2 9HT

1 studies enrolling now · 3 studies all time

What they study most

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Urinary Bladder Neoplasms

Studies at this site

• A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy — Running, not enrolling
• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder — Completed